Earnings release
Page 1
Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 BANNOCKBURN, IL., July 29, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights (year-over-year comparisons unless otherwise noted) • Net revenue of $1,442 million, up 1.9% • GAAP net income of $53.9 million, up 6.7% • GAAP diluted earnings per share of $0.35, up 12.9% • Adjusted EBITDA of $117.5 million, up 3.0% • Adjusted diluted earnings per share of $0.45, up 9.8% • Cash provided by Q2 operating activities of $184 million • Repurchased $150 million of outstanding shares in the quarter John C. Rademacher, Chief Executive Officer, commented, “I’m proud of our team as we delivered strong second quarter results, reflecting solid operational execution and the positive impact of our 2026 strategic initiatives. Looking ahead, our results reinforce our confidence in the underlying fundamentals of the business, but there is still work to do as we further position the company for a sustainable long-term growth trajectory. Given the strength of our clinical platform, significant market opportunities and our operational focus, we believe we are well positioned to achieve our 2026 priorities while creating meaningful value for our patients, partners, and shareholders.” Updated Full Year and Third Quarter 2026 Financial Guidance For the full year 2026, Option Care Health expects the following: • Net revenue of $5.675 billion to $5.775 billion • Adjusted diluted earnings per share of $1.85 to $1.92 • Adjusted EBITDA of $480 million to $495 million • Cash provided by operating activities of at least $320 million For the third quarter 2026, Option Care Health expects the following compared to the second quarter 2026: • Sequential net revenue growth in the low to mid single-digits • Sequential Adjusted EBITDA growth in the mid single-digits
Page 2
Conference Call Option Care Health will host a conference call to discuss its results on Wednesday, July 29, 2026, at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available at the same web link for 90 days after the call. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members, including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com. Investor Contact Bob Okunski Vice President, Investor Relations investor.relations@optioncare.com
Page 3
Forward-Looking Statements - Safe Harbor This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements the Company may make regarding future revenues, future earnings, other future financial results, regulatory developments, market developments, new products and growth strategies and the effects of any of the foregoing on its future results of operations or financial condition. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws, regulations or trade policies applicable to its business model; loss of relationships with managed care organizations and other non-governmental third party payers; changes in the pharmaceutical industry, including limiting or discontinuing research, development, production and marketing of pharmaceuticals compatible with its services; changes in market conditions and receptivity to its services and offerings; and pending and future litigation or potential liability for claims not covered by insurance. For a detailed discussion of the risk factors that could affect its actual results, please refer to the risk factors identified in the Company's SEC reports as filed with the SEC. Any forward-looking statement made by the Company in this press release is based only on information currently available to it and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Page 4
Note Regarding Use of Non-GAAP Financial Measures In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted diluted earnings per share ("EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, EPS, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non- GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted diluted EPS represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long ‑ lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health’s business operations and facilitate comparisons to the Company’s historical operating results. The Company has not reconciled Adjusted EBITDA guidance to net income or Adjusted diluted EPS guidance to GAAP diluted EPS as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each historical adjusted measure to the most comparable GAAP financial measure are set forth below.
Page 5
Schedule 1 OPTION CARE HEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS)(UNAUDITED) June 30, 2026 December 31, 2025 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 193,767 $ 232,624 Accounts receivable, net 511,507 473,566 Inventories 399,605 471,149 Prepaid expenses and other current assets 95,713 87,629 Total current assets 1,200,592 1,264,968 NONCURRENT ASSETS: Property and equipment, net 140,408 139,236 Intangible assets, net 20,229 21,897 Referral sources, net 270,410 287,281 Goodwill 1,606,743 1,606,743 Other noncurrent assets 140,395 135,644 Total noncurrent assets 2,178,185 2,190,801 TOTAL ASSETS $ 3,378,777 $ 3,455,769 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable $ 639,767 $ 639,829 Other current liabilities 179,710 189,519 Total current liabilities 819,477 829,348 NONCURRENT LIABILITIES: Long-term debt, net of discount, deferred financing costs and current portion 1,152,040 1,154,052 Other noncurrent liabilities 147,362 145,976 Total noncurrent liabilities 1,299,402 1,300,028 Total liabilities 2,118,879 2,129,376 STOCKHOLDERS’ EQUITY 1,259,898 1,326,393 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 3,378,777 $ 3,455,769
Page 6
Schedule 2 OPTION CARE HEALTH, INC. CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 NET REVENUE $ 1,442,400 $ 1,416,085 $ 2,793,054 $ 2,749,057 COST OF REVENUE 1,175,149 1,147,042 2,263,789 2,216,962 GROSS PROFIT 267,251 269,043 529,265 532,095 OPERATING COSTS AND EXPENSES: Selling, general and administrative expenses 161,110 167,467 331,065 330,275 Restructuring, acquisition, integration and other 3,549 2,625 8,156 7,935 Depreciation and amortization expense 17,452 16,241 32,359 31,987 Total operating expenses 182,111 186,333 371,580 370,197 OPERATING INCOME 85,140 82,710 157,685 161,898 OTHER INCOME (EXPENSE): Interest expense, net (14,020) (14,447) (27,324) (27,678) Other, net 2,867 598 4,629 (1,803) Total other (expense) income (11,153) (13,849) (22,695) (29,481) INCOME BEFORE INCOME TAXES 73,987 68,861 134,990 132,417 INCOME TAX EXPENSE 20,074 18,338 35,734 35,152 NET INCOME $ 53,913 $ 50,523 $ 99,256 $ 97,265 Earnings per share, basic $ 0.35 $ 0.31 $ 0.64 $ 0.59 Earnings per share, diluted $ 0.35 $ 0.31 $ 0.64 $ 0.59 Weighted average common shares outstanding, basic 152,931 162,931 154,782 164,188 Weighted average common shares outstanding, diluted 153,485 164,133 155,772 165,402
Page 7
Schedule 3 OPTION CARE HEALTH, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)(UNAUDITED) Six Months Ended June 30, 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 99,256 $ 97,265 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization expense 34,037 33,326 Other adjustments 31,535 35,857 Changes in operating assets and liabilities: Accounts receivable, net (37,941) (61,392) Inventories 71,544 (12,718) Prepaid expenses and other current assets (9,958) 17,606 Accounts payable 2,610 (27,904) Accrued compensation and employee benefits (4,188) 8,730 Other (15,410) (7,651) Net cash provided by operating activities 171,485 83,119 CASH FLOWS FROM INVESTING ACTIVITIES: Acquisition of property and equipment (20,123) (18,466) Business acquisitions, net of cash acquired — (117,247) Other investing activities (877) — Net cash used in investing activities (21,000) (135,713) CASH FLOWS FROM FINANCING ACTIVITIES: Purchase of company stock and related excise taxes (170,545) (152,429) Other financing activities (18,797) (8,724) Net cash used in financing activities (189,342) (161,153) NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (38,857) (213,747) Cash and cash equivalents - beginning of period 232,624 412,565 CASH AND CASH EQUIVALENTS - END OF PERIOD $ 193,767 $ 198,818
Page 8
Schedule 4 OPTION CARE HEALTH, INC. QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Net income $ 53,913 $ 50,523 $ 99,256 $ 97,265 Interest expense, net 14,020 14,447 27,324 27,678 Income tax expense 20,074 18,338 35,734 35,152 Depreciation and amortization expense 18,382 16,953 34,037 33,326 EBITDA 106,389 100,261 196,351 193,421 EBITDA adjustments Stock-based incentive compensation expense 8,382 10,712 18,581 19,513 Restructuring, acquisition, integration and other (1) 2,711 3,045 7,320 12,850 Adjusted EBITDA $ 117,482 $ 114,018 $ 222,252 $ 225,784 Net income $ 53,913 $ 50,523 $ 99,256 $ 97,265 Intangible asset amortization expense 9,269 9,297 18,539 18,394 Stock-based incentive compensation expense 8,382 10,712 18,581 19,513 Restructuring, acquisition, integration and other (1) 2,711 3,045 7,320 12,850 Total pre-tax adjustments 20,362 23,054 44,440 50,757 Tax adjustments (2) (5,589) (6,109) (11,777) (13,451) Adjusted net income $ 68,686 $ 67,468 $ 131,919 $ 134,571 Earnings per share, diluted $ 0.35 $ 0.31 $ 0.64 $ 0.59 Adjusted earnings per share, diluted $ 0.45 $ 0.41 $ 0.85 $ 0.81 Weighted average common shares outstanding, diluted 153,485 164,133 155,772 165,402 (1) Restructuring, acquisition, integration and other includes $3,549 and $8,156 of operating expenses for the three and six months ended June 30, 2026, respectively. Restructuring, acquisition, integration and other includes $2,625 and $7,935 of operating expenses for the three and six months ended June 30, 2025, respectively. (2) Tax adjustments for the three and six months ended June 30, 2026 and 2025 includes the estimated income tax effect on non-GAAP adjustments based on the effective tax rate.